Test Code LABMRDLLPAML MRD Leukemia/Lymphoma Panel-AML
Additional Codes
| Test Name in EPIC | EPIC Test Code | Mnemonic |
|---|---|---|
| MRD Leukemia/Lymphoma Panel-AML | LABMRDLLPAML | MRDLLPAML |
Performing Laboratory
University of Washington Lab Medicine, Hematopathology
Specimen Type
Blood or Bone Marrow
Specimen Required
Purple top EDTA, Green top Na Hep
Blood
1-6mL LAVENDER TOP (EDTA) or GREEN TOP (HEPARIN) tube; store at ambient temperature or refrigerated.
Bone Marrow
First pull collected in LAVENDER TOP (EDTA) or GREEN TOP (HEPARIN) tube; store at ambient temperature or refrigerated.
Bone Marrow Biopsy
Submerged in RPMI media stored at 3-5C (REFRIGERATED)
Specimen Stability Information
Blood
1-6mL LAVENDER TOP (EDTA) or GREEN TOP (HEPARIN) tube; store at ambient temperature or refrigerated.
Bone Marrow
First pull collected in LAVENDER TOP (EDTA) or GREEN TOP (HEPARIN) tube; store at ambient temperature or refrigerated.
Bone Marrow Biopsy
Submerged in RPMI media stored at 3-5C (REFRIGERATED)
Handling Instructions
Since flow cytometry is based on evaluation of living cells, specimens should be received within 48 hours of collection for optimal viability. A disclaimer statement regarding limited assay sensitivity due to specimen age may be included in reports for specimens received >72 hours from collection.
Specimens must be received in the laboratory within 7 days of collection for diagnostic or tissue samples, and 5 days for MRD testing. Specimens received beyond these criteria may be rejected upon receipt.
The above packaging, transport, and shipping guidelines generally provide acceptable sample quality. However, it is at the discretion of the Pathologist to determine whether the resulting data is unacceptable or non-diagnostic.
Rejection Criteria:
· Specimens received in the laboratory >7 days of collection for diagnostic or tissue samples, or >5 days for MRD testing
· Samples received frozen
· Specimen drawn into tubes containing anticoagulant different from specific requirements.
· Specimen drawn into tubes with separator gel, even if not spun
· Clotted (Note: Clotted sample will be disaggregated for testing. Data will be evaluated by Pathologist before sample is rejected.)
· Mislabeled or inadequately-labeled specimens
· Leaking/broken container with no specimen left inside container
· Quantity of sample not sufficient to perform test
· Severely hemolyzed specimen
Method and Method Description
Flow Cytometry
Useful For/Utility
CD20 evaluation for Anti-CD20 therapy by flow cytometry, Immunophenotyping, Leukemia or Lymphoma by Flow Cytometry, Rituxan Monitoring, Rituximab Monitoring
Clinical Information
Flow cytometry: This testing may be performed to evaluate antigens expressed by hematopoietic cells. The most common use of flow cytometry is to evaluate for involvement by a hematopoietic neoplasm (for instance leukemia, lymphoma, plasma cell neoplasm, or chronic myeloid neoplasm). Evaluation may include characterization of expression of up to 45 CD markers using antibodies labeled with a fluorescent marker.
CPT(s)
88184
88189
88185
Additional charges if appropriate